Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of acetylcysteine in first-line therapy to cure Helicobacter pylori (pilot study)
2009-011978-15Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetylcysteine in Helicobacter pylori infection, Peptic ulcer disease (PUD), duodenal ulcer and 1 more, sponsored by Policlinico Gemelli. Primary endpoint: Helicobacter pylori eradication. Started Apr 2009; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)duodenal ulcergastric ulcer
Beyond the preview
Go deeper on 2009-011978-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011978-15.